No doubt in my mind Bard1 lung will come back to life and be an integral part of the product portfolio, but the test on 638 samples back in 2017 didn't do what was needed (Ann 15/5/17) and was sent back to the drawing board - despite the positive feasibility study. The black hole in SP was mid 3's down to 1c.
A lot has happened in 2 years and it's onwards and upwards.
Performance Shares, page-20
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
58.0¢ |
Change
0.015(2.65%) |
Mkt cap ! $63.96M | |||
| Open | High | Low | Value | Volume |
| 56.5¢ | 58.0¢ | 56.0¢ | $38.51K | 68.38K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2293 | 56.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 58.0¢ | 13111 | 1 |
View Market Depth
| Last trade - 15.48pm 12/07/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |